As described above, when ZEB1/2 were upregulated and maintained at high levels in aggressive cancer cells, the IIIc isoforms of FGFRs were expressed through isoform switching when ESRP1/2 expression was repressed. This evidence concerns the gene ESRP1 and cancer.